Literature DB >> 16469639

Characterization of a panel of cell lines derived from urothelial neoplasms: genetic alterations, growth in vivo and the relationship of adenoviral mediated gene transfer to coxsackie adenovirus receptor expression.

Anita Sabichi1, Afsaneh Keyhani, Noriyoshi Tanaka, Jorge Delacerda, I-Ling Lee, Changping Zou, Jain-Hua Zhou, William F Benedict, H Barton Grossman.   

Abstract

PURPOSE: Cell lines have become an essential component for the investigation of cancer. We have developed a panel of cell lines derived from human urothelial cancers and we describe some of their important characteristics.
MATERIALS AND METHODS: Ten human urothelial cancer cell lines were characterized by their growth in athymic nude mice, CAR expression and their susceptibility to adenoviral mediated transfer of the green fluorescence protein gene. TP53 mutation status and immunochemical analysis of p53, pRB and p16 were also examined.
RESULTS: Five cell lines rapidly produced tumors in athymic nude mice. Two cell lines produced tumors in 1 month, 1 produced them in 3 months and 2 were nontumorigenic. The cell lines varied in CAR expression and in their susceptibility to adenoviral mediated gene transduction. There was no direct correlation between CAR expression and susceptibility to adenoviral mediated gene transduction. Seven cell lines had TP53 mutations, of which 2 had large deletions and did not express p53 protein by immunostaining. All cell lines expressed abnormal pRB by immunochemical analysis (3 had no staining and 7 had homogenously strong staining) and 8 did not express p16 (7 showed homogeneously strong pRB staining).
CONCLUSIONS: Our panel of 10 human urothelial cell lines differed in genetic alterations, growth in nude mice, susceptibility to adenoviral mediated gene transduction, and expression of p53, p16 and pRB. The availability of various urothelial cancer cell lines with differing genotypic and phenotypic features will facilitate further research into bladder cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16469639     DOI: 10.1016/S0022-5347(05)00323-X

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  23 in total

1.  Identification of genes correlated with early-stage bladder cancer progression.

Authors:  Randolph Stone; Anita L Sabichi; Jennifer Gill; I-Ling Lee; Patrick Adegboyega; Michael S Dai; Raja Loganantharaj; Marjan Trutschl; Urska Cvek; John L Clifford
Journal:  Cancer Prev Res (Phila)       Date:  2010-05-25

2.  Fibulin-3 promotes muscle-invasive bladder cancer.

Authors:  A L Han; B A Veeneman; L El-Sawy; K C Day; M L Day; S A Tomlins; E T Keller
Journal:  Oncogene       Date:  2017-05-15       Impact factor: 9.867

3.  The p63 protein isoform ΔNp63α inhibits epithelial-mesenchymal transition in human bladder cancer cells: role of MIR-205.

Authors:  Mai N Tran; Woonyoung Choi; Matthew F Wszolek; Neema Navai; I-Ling C Lee; Giovanni Nitti; Sijin Wen; Elsa R Flores; Arlene Siefker-Radtke; Bogdan Czerniak; Colin Dinney; Michelle Barton; David J McConkey
Journal:  J Biol Chem       Date:  2012-12-13       Impact factor: 5.157

4.  Quantitation of Aurora kinase A gene copy number in urine sediments and bladder cancer detection.

Authors:  Hong-Seok Park; Weon Seo Park; Jolanta Bondaruk; Noriyoshi Tanaka; Hiroshi Katayama; Sangkyou Lee; Philippe E Spiess; Jordan R Steinberg; Zhi Wang; Ruth L Katz; Colin Dinney; Keren J Elias; Yair Lotan; Rizwan C Naeem; Keith Baggerly; Subrata Sen; H Barton Grossman; Bogdan Czerniak
Journal:  J Natl Cancer Inst       Date:  2008-09-23       Impact factor: 13.506

5.  Integrin alphavbeta5 is a primary receptor for adenovirus in CAR-negative cells.

Authors:  Cynthia Lyle; Frank McCormick
Journal:  Virol J       Date:  2010-07-08       Impact factor: 4.099

6.  The use of short tandem repeat profiling to characterize human bladder cancer cell lines.

Authors:  Edmund Chiong; Ali Dadbin; Loleta D Harris; Anita L Sabichi; H Barton Grossman
Journal:  J Urol       Date:  2009-04-17       Impact factor: 7.450

7.  Early RB94-produced cytotoxicity in cancer cells is independent of caspase activation or 50 kb DNA fragmentation.

Authors:  J Zhou; X-Q Zhang; F Ashoori; D J McConkey; M A Knowles; L Dong; W F Benedict
Journal:  Cancer Gene Ther       Date:  2008-07-25       Impact factor: 5.987

8.  Evaluation of the antitumor activity of dacomitinib in models of human bladder cancer.

Authors:  Petros D Grivas; Kathleen C Day; Andreas Karatsinides; Alyssa Paul; Nazia Shakir; Iya Owainati; Monica Liebert; Lakshmi P Kunju; Dafydd Thomas; Maha Hussain; Mark L Day
Journal:  Mol Med       Date:  2013-11-08       Impact factor: 6.354

Review 9.  [Bladder carcinoma cell lines as models of the pathobiology of bladder cancer. Review of the literature and establishment of a new progression series].

Authors:  J Hatina; W Huckenbeck; H Rieder; H-H Seifert; W A Schulz
Journal:  Urologe A       Date:  2008-06       Impact factor: 0.639

10.  ARID1A alterations are associated with FGFR3-wild type, poor-prognosis, urothelial bladder tumors.

Authors:  Cristina Balbás-Martínez; María Rodríguez-Pinilla; Ariel Casanova; Orlando Domínguez; David G Pisano; Gonzalo Gómez; Josep Lloreta; José A Lorente; Núria Malats; Francisco X Real
Journal:  PLoS One       Date:  2013-05-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.